Scott W Morrison is Director of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 6,637 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Scott W Morrison Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2022
SELL
Sale (or disposition) back to the issuer
-
6,637 Reduced 100.0%
0 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
-
3,600 Added 35.17%
6,637 Common Stock
Sep 09 2021
SELL
Open market or private sale
$145,008 $30.21 p/Share
4,800 Reduced 61.25%
3,037 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
-
3,037 Added 27.93%
7,837 Common Stock

Also insider at

VERA
Vera Therapeutics, Inc. Healthcare
IDYA
IDEAYA Biosciences, Inc. Healthcare
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
ZLAB
Zai Lab Ltd Healthcare
TARS
Tarsus Pharmaceuticals, Inc. Healthcare
SWM

Scott W Morrison

Director
Burlingame, CA

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT